Evidence map›Paper›PMID 32938979›Full record

ArticleScientific reports2020

Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract.

David M Johanson, Jennifer E Goertz, Ioana A Marin, John Costello, Christopher C Overall, Alban Gaultier

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Specific microbial ratio in the gut microbiome is associated with multiple sclerosis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Yerba Mate (Nutrients · 2025
    Article
  11. Colonization byFrontiers in immunology · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Thinking outside the brain: Gut microbiome influence on innate immunity within neurodegenerative disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

David M JohansonCenter for Brain Immunology and Glia, University of Virginia, Charlottesville, VA, 22908, USA.
Jennifer E GoertzCenter for Brain Immunology and Glia, University of Virginia, Charlottesville, VA, 22908, USA.
Ioana A MarinCenter for Brain Immunology and Glia, University of Virginia, Charlottesville, VA, 22908, USA.
John CostelloCenter for Brain Immunology and Glia, University of Virginia, Charlottesville, VA, 22908, USA.
Christopher C OverallCenter for Brain Immunology and Glia, University of Virginia, Charlottesville, VA, 22908, USA.
Alban GaultierCenter for Brain Immunology and Glia, University of Virginia, Charlottesville, VA, 22908, USA. ag7h@virginia.edu.
University of Virginia · USCornell University · USMyriad Genetics · US

Funding

Meningeal immunity - a middleman between gut microbiome and the brainR33MH108156 · NIMH · UNIVERSITY OF VIRGINIA · PI GAULTIER, ALBAN P, KIPNIS, JONATHAN · 2017 to 2019
$1.3M
Biodefense Short-Term Training for Minority StudentT35AI060528 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HALME, ADRIAN J, PETRI, WILLIAM A · 2004 to 2024
$1.3M
Multiple Sclerosis Society PP1412NIAID NIH HHS T35 AI060528NIMH NIH HHS R33 MH108156NIMH NIH HHS R33MH108156
6 · The paper itself

Abstract

The gut microbiome is known to be sensitive to changes in the immune system, especially during autoimmune diseases such as Multiple Sclerosis (MS). Our study examines the changes to the gut microbiome that occur during experimental autoimmune encephalomyelitis (EAE), an animal model for MS. We collected fecal samples at key stages of EAE progression and quantified microbial abundances with 16S V3-V4 amplicon sequencing. Our analysis of the data suggests that the abundance of commensal Lactobacillaceae decreases during EAE while other commensal populations belonging to the Clostridiaceae, Ruminococcaceae, and Peptostreptococcaceae families expand. Community analysis with microbial co-occurrence networks points to these three expanding taxa as potential mediators of gut microbiome dysbiosis. We also employed PICRUSt2 to impute MetaCyc Enzyme Consortium (EC) pathway abundances from the original microbial abundance data. From this analysis, we found that a number of imputed EC pathways responsible for the production of immunomodulatory compounds appear to be enriched in mice undergoing EAE. Our analysis and interpretation of results provides a detailed picture of the changes to the gut microbiome that are occurring throughout the course of EAE disease progression and helps to evaluate EAE as a viable model for gut dysbiosis in MS patients.

Indexed as

AnimalsClostridiaceaeDisease Models, AnimalDysbiosisEncephalomyelitis, Autoimmune, ExperimentalFecesFemaleGastrointestinal MicrobiomeHumansImmunomodulationLactobacillaceaeMiceMice, Inbred C57BLMultiple SclerosisPeptostreptococcusRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID32938979
PMCPMC7494894
OpenAlexW3087541471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.